CBL & Associates Properties is a strong Buy as AFFO growth, stock buybacks, and rate cuts drive value in the retail REIT ...

Airbnb's Q2 results reveal slowed growth in key markets amid economic risks. High valuation multiples leave little margin for ...

Zepp Health's Amazfit brand drives revenue growth. Read here for more on ZEPP stock's health-focused wearables, AI tech, and ...

Wayfair's +5% net revenue growth in Q2 2025 was quite good, and it mentioned strong Q3 2025 QTD results too. Read more on W ...

Corcept's Q2 2025 saw 60% therapy demand growth despite bottlenecks. Despite near-term operational risks, we maintain ...

CoreWeave thrives as a leading AI infrastructure provider, fueled by GenAI growth and a $11.9B OpenAI deal. Read here for ...

Valvoline's growth strategy remains strong despite macroeconomic challenges. VVV stock has continued to expand the franchise ...

Giverny Capital reshapes its portfolio with trims to Progressive and exits from M&T, while doubling down on Kinsale and ...

Baron Capital highlights biotech and robotic surgery as key growth drivers in Q2. See which stocks surged, which stumbled, ...

Day One Biopharmaceuticals poised for growth with OJEMDA success and FIREFLY-2 catalysts. See here to know why we are bullish ...

Despite short-term headwinds, UnitedHealth offers strong upside in the medium term. See more o UNH stock's Q2 challenges and ...

Nuveen S&P 500 Dynamic Overwrite Fund underperforms its peers and lacks downside protection. See here to know why we are ...